CD4 and neoplasm: Rich infiltration of CD8 + tumor-infiltrating lymphocytes, CD4 + T helper cells and activation of type I interferon signaling were associated with the signature of dMMR-MSI colon cancer, which was considered to benefit from immunotherapy [49].